Australian Clinical Labs Ltd (ACL) - Total Liabilities
Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) has total liabilities worth AU$411.46 Million AUD (≈ $291.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ACL operating cash flow to assess how effectively this company generates cash.
Australian Clinical Labs Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how Australian Clinical Labs Ltd's total liabilities have evolved over time, based on quarterly financial data. Check ACL asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Australian Clinical Labs Ltd Competitors by Total Liabilities
The table below lists competitors of Australian Clinical Labs Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bourse Direct SA
PA:BSD
|
France | €1.20 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$284.53 Million |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩92.52 Billion |
|
Hydratec Industries NV
AS:HYDRA
|
Netherlands | €104.49 Million |
|
Kepler Weber S.A
SA:KEPL3
|
Brazil | R$825.13 Million |
|
Launch Two Acquisition Corp. Class A Ordinary Shares
NASDAQ:LPBB
|
USA | $11.11 Million |
|
Gyldendal A/S
CO:GYLD-A
|
Denmark | Dkr290.27 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Australian Clinical Labs Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Australian Clinical Labs Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.11 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Australian Clinical Labs Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Australian Clinical Labs Ltd (2016–2025)
The table below shows the annual total liabilities of Australian Clinical Labs Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$402.86 Million ≈ $285.05 Million |
0.00% |
| 2024-12-31 | AU$402.86 Million ≈ $285.05 Million |
-2.99% |
| 2024-06-30 | AU$415.30 Million ≈ $293.85 Million |
0.00% |
| 2023-12-31 | AU$415.30 Million ≈ $293.85 Million |
+2.23% |
| 2023-06-30 | AU$406.24 Million ≈ $287.44 Million |
0.00% |
| 2022-12-31 | AU$406.24 Million ≈ $287.44 Million |
+2.72% |
| 2022-06-30 | AU$395.49 Million ≈ $279.83 Million |
0.00% |
| 2021-12-31 | AU$395.49 Million ≈ $279.83 Million |
+0.69% |
| 2021-06-30 | AU$392.79 Million ≈ $277.92 Million |
0.00% |
| 2020-12-31 | AU$392.79 Million ≈ $277.92 Million |
+32.22% |
| 2020-06-30 | AU$297.06 Million ≈ $210.19 Million |
0.00% |
| 2019-12-31 | AU$297.06 Million ≈ $210.19 Million |
+135.41% |
| 2019-06-30 | AU$126.19 Million ≈ $89.29 Million |
0.00% |
| 2018-12-31 | AU$126.19 Million ≈ $89.29 Million |
+11.08% |
| 2018-06-30 | AU$113.60 Million ≈ $80.38 Million |
0.00% |
| 2017-12-31 | AU$113.60 Million ≈ $80.38 Million |
+6.40% |
| 2017-06-30 | AU$106.77 Million ≈ $75.55 Million |
0.00% |
| 2016-12-31 | AU$106.77 Million ≈ $75.55 Million |
-- |
About Australian Clinical Labs Ltd
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veter… Read more